Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

USHER SYNDROME

Clinical trials for USHER SYNDROME explained in plain language.

Never miss a new study

Get alerted when new USHER SYNDROME trials appear

Sign up with your email to follow new studies for USHER SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1
Sort by
  • New drug aims to preserve sight in rare genetic blindness

    Disease control Not yet recruiting

    This phase 3 trial tests whether NPI-001, taken twice daily for 24 months, can slow the loss of light-sensing cells in the eyes of adults with Usher syndrome, a genetic condition that causes both hearing and vision loss. About 80 participants will receive either the drug or a pla…

    Matched conditions: USHER SYNDROME

    Phase: PHASE3 • Sponsor: Nacuity Pharmaceuticals, Inc. • Aim: Disease control

    Last updated Jul 02, 2026 05:00 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space